Express Pharma

US FDA grants EIR to Lupin’s Ankleshwar manufacturing facility

The inspection of the facility was conducted from 16th to 19th August, 2022

1 116

The US Food and Drug Administration (FDA) has granted Establishment Inspection Report (EIR) to Lupin’s Ankleshwar manufacturing facility, located in Gujarat, according to a statement by Lupin.

The statement informed that the inspection of the facility was conducted from 16th to 19th August, 2022.

- Advertisement -

1 Comment
  1. soundos says

    Your blog is very informative. thanks for Sharing this blog.

Leave A Reply

Your email address will not be published.